HONG KONG, Oct. 20 /PRNewswire-Asia-FirstCall/ -- China Cord
Blood Corporation ("CCBC" or "the Company") (NYSE: CO), the first
and largest cord blood bank operator in China, today announced that the Company has
filed an amendment to its Annual Report on Form 20-F/A, which
included audited financial statements for the fiscal year ended
March 31, 2010 with the U.S.
Securities and Exchange Commission. The Form 20-F/A can be accessed
by visiting the U.S. Securities and Exchange Commission's website
at www.sec.gov and can also be found at CCBC's website at
http://www.chinacordbloodcorp.com , under Investor Relations. CCBC
will provide a hard copy of the Annual Report, including a complete
set of audited financial statements, free of charge to any
shareholder upon request.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest cord blood
banking operator in China in terms
of geographical coverage and is the only cord blood bank operator
with multiple licenses. Under the current PRC government
regulations, only one licensed cord blood bank operator is
permitted to operate in each licensed region and only seven
licenses have been authorized as of today. China Cord Blood
Corporation provides cord blood collection, laboratory testing,
hematopoietic stem cell processing, and stem cell storage services.
For more information, please visit our website at
http://www.chinacordbloodcorp.com .
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, performance and
results of operations, and underlying assumptions and other
statements that are other than statements of historical facts.
These statements are subject to uncertainties and risks including,
but not limited to, product and service demand and acceptance,
changes in technology, economic conditions, the impact of
competition and pricing, government regulation, and other risks
contained in statements filed from time to time with the Securities
and Exchange Commission. All such forward-looking statements,
whether written or oral, and whether made by or on behalf of the
Company, are expressly qualified by the cautionary statements and
any other cautionary statements which may accompany the
forward-looking statements. In addition, the Company disclaims any
obligation to update any forward-looking statements to reflect
events or circumstances after the date hereof.
For more information, please contact:
China Cord Blood Corporation
Ms. Joeling Law
Tel: +852-3605-8180
Email: ir@chinacordbloodcorp.com
ICR, LLC
In New York:
Ashley M. Ammon or Christine Duan
Tel: +1-646-277-1227
In Beijing:
Wen Lei Zheng
Tel: +86-10-6599-7968
SOURCE China Cord Blood Corporation
Copyright . 20 PR Newswire